JW LIFESCIENCE CORPORATION Logo

JW LIFESCIENCE CORPORATION

A leading developer and manufacturer of infusion solutions, from basic IV fluids to complex nutrients.

234080 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
충청남도 당진시 송악읍 한진1길 28, 당진시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

JW Life Science Corporation is a leading developer and manufacturer specializing in infusion solutions. The company's core business involves producing a wide range of products, from basic intravenous (IV) fluids to complex nutrient infusion solutions that provide patients with essential amino acids, lipids, vitamins, and minerals. Operating state-of-the-art facilities like the JW Dangjin Production Complex, JW Life Science is a prominent player in its domestic market with a focus on expanding its global presence. The company is committed to advancing public health through continuous research and development, utilizing its platform technologies and research network to enhance its product pipeline and contribute to the pharmaceutical industry.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for JW LIFESCIENCE CORPORATION and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 1.2 MB
2025-08-26 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 1.3 MB

Automate Your Workflow. Get a real-time feed of all JW LIFESCIENCE CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for JW LIFESCIENCE CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
A global supplier of generic APIs using AI to accelerate drug development.
South Korea 041910
Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea 335810
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea 334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore 950210
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea 296160
PROTEINA CO.,LTD. Logo
A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.
South Korea 468530
PROTIA INC. Logo
Develops IVD kits and instruments for allergy, POCT, infectious & autoimmune diseases.
South Korea 303360

Talk to a Data Expert

Have a question? We'll get back to you promptly.